India
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 46.94 M
|
March 31, 2024 | USD 1.84 | 1.24% |
|
India |
|
2 |
USD 11.32 M
|
March 31, 2024 | USD 1.48 | 10.54% |
|
India |
|
3 |
USD 4.53 M
|
March 31, 2024 | USD 10.41 | 0.07% |
|
India |
|
4 |
USD 2.61 M
|
March 31, 2024 | USD 83.39 | -0.45% |
|
India |
|
5 |
USD 2.29 M
|
March 31, 2024 | USD 2.13 | 3.60% |
|
India |
|
6 |
USD 1.23 M
|
March 31, 2024 | USD 3.94 | 4.92% |
|
India |
|
7 |
USD 915.60 K
|
March 31, 2024 | USD 0.08 | -1.16% |
|
India |
|
8 |
USD 39.88 K
|
March 31, 2024 | USD 0.59 | -0.38% |
|
India |
|
9 |
USD -47.69 K
|
March 31, 2024 | USD 0.30 | -2.89% |
|
India |
|
10 |
USD -246.99 K
|
March 31, 2024 | USD 1.75 | -0.77% |
|
India |
|
11 |
USD -387.81 K
|
March 31, 2024 | USD 0.62 | 0.29% |
|
India |
|
12 |
USD -847.49 K
|
March 31, 2024 | USD 0.48 | 2.73% |
|
India |
|
13 |
USD -937.14 K
|
March 31, 2024 | USD 1.15 | 4.92% |
|
India |
|
14 |
USD -1.13 M
|
March 31, 2024 | USD 1.05 | -0.73% |
|
India |
|
15 |
USD -1.21 M
|
March 31, 2024 | USD 7.28 | -0.74% |
|
India |
|
16 |
USD -1.35 M
|
March 31, 2024 | USD 7.36 | -0.60% |
|
India |
|
17 |
USD -1.43 M
|
March 31, 2024 | USD 1.90 | 1.06% |
|
India |
|
18 |
USD -2.72 M
|
March 31, 2024 | USD 22.57 | -4.38% |
|
India |
|
19 |
USD -2.91 M
|
March 31, 2024 | USD 32.88 | -0.93% |
|
India |
|
20 |
USD -3.29 M
|
March 31, 2024 | USD 1.95 | 1.88% |
|
India |
|
21 |
USD -4.70 M
|
March 31, 2024 | USD 2.62 | 1.34% |
|
India |
|
22 |
USD -7.75 M
|
March 31, 2024 | USD 3.80 | -0.08% |
|
India |
|
23 |
USD -9.12 M
|
March 31, 2024 | USD 9.86 | 2.71% |
|
India |
|
24 |
USD -9.49 M
|
March 31, 2024 | USD 28.13 | 1.29% |
|
India |
|
25 |
USD -16.42 M
|
March 31, 2024 | USD 16.33 | 9.92% |
|
India |
|
26 |
USD -18.01 M
|
March 31, 2024 | USD 7.90 | 4.00% |
|
India |
|
27 |
USD -18.54 M
|
March 31, 2024 | USD 24.83 | 4.19% |
|
India |
|
28 |
USD -20.13 M
|
March 31, 2024 | USD 37.68 | -2.72% |
|
India |
|
29 |
USD -20.83 M
|
March 31, 2024 | USD 4.09 | 2.01% |
|
India |
|
30 |
USD -32.25 M
|
March 31, 2024 | USD 64.29 | -2.83% |
|
India |
|
31 |
USD -37.75 M
|
March 31, 2024 | USD 0.81 | -1.02% |
|
India |
|
32 |
USD -42.36 M
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
33 |
USD -43.43 M
|
March 31, 2024 | USD 12.16 | 1.55% |
|
India |
|
34 |
USD -47.01 M
|
March 31, 2024 | USD 7.98 | 1.95% |
|
India |
|
35 |
USD -59.42 M
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
36 |
USD -68.28 M
|
March 31, 2024 | USD 8.03 | -0.57% |
|
India |
|
37 |
USD -72.88 M
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
38 |
USD -98.60 M
|
March 31, 2024 | USD 6.73 | -0.82% |
|
India |
|
39 |
USD -120.43 M
|
March 31, 2024 | USD 4.18 | 1.48% |
|
India |
|
40 |
USD -120.91 M
|
March 31, 2024 | USD 58.36 | 0.18% |
|
India |
|
41 |
USD -176.86 M
|
March 31, 2024 | USD 11.18 | 1.69% |
|
India |
|
42 |
USD -205.28 M
|
March 31, 2024 | USD 23.98 | 0.71% |
|
India |
|
43 |
USD -297.09 M
|
March 31, 2024 | USD 6.96 | 6.42% |
|
India |
|
44 |
USD -482.95 M
|
March 31, 2024 | USD 14.03 | 1.84% |
|
India |
|
45 |
USD -543.92 M
|
March 31, 2024 | USD 13.51 | -1.02% |
|
India |
The Biotechnology company in India with the highest Net Cash Used For Investing Activities is Sun Pharma Advanced Research Company Limited (NSE: SPARC.NS) at USD 46.94 M.
The Biotechnology company in India with the lowest Net Cash Used For Investing Activities is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD -543.92 M.
The top 10 Biotechnology companies in India by Net Cash Used For Investing Activities are Sun Pharma Advanced Research Company Limited, Suven Life Sciences Limited, Kaveri Seed Company Limited, AstraZeneca Pharma India Limited, Agri-tech (India) Limited, Panacea Biotec Limited, Ajooni Biotech Limited, Vineet Laboratories Limited, Lasa Supergenerics Limited and Bombay Super Hybrid Seeds Limited.
The bottom 10 Biotechnology companies in India by Net Cash Used For Investing Activities are Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, UPL Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Limited, Biocon Limited, Laurus Labs Limited, Jubilant Pharmova Limited and Jubilant Ingrevia Limited.